Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma

Androgen deprivation therapy (ADT) is widely used in the treatment of testosterone-dependent prostate carcinomas. ADT often increases plasma LDL and HDL cholesterol and triglycerides. The aim was to test wheth...

Source: Lipids in Health and Disease - June 10, 2020 Category: Lipidology Authors: Cicero P. Albuquerque, Fatima R. Freitas, Ana Elisa M. Martinelli, Josefa H. Lima, Rafael F. Coelho, Carlos V. Serrano Jr., Willian C. Nahas, Roberto Kalil Filho and Raul C. Maranh ão Tags: Research Source Type: research